Diese Seite verwendet Cookies, wie in unserer beschrieben Cookie-Richtlinie. Um zu sehen, welche Cookies wir verwenden, besuchen Sie bitte unsere Cookie-Einstellungsfeld. Ich stimme dieser Cookie-Richtlinie zu, diese Nachricht nicht mehr anzeigen

Veranstaltung am

How can POCT benefit healthcare professionals in diagnosing and managing diabetes and comorbidities?

Zusammenfassung

Join our panel of experts from around the world - USA, Japan and Switzerland - to learn how they use point of care testing for the management of their patients with diabetes and comorbidities.

This webinar will be chaired by Dr. Vivian Fonseca, an endocrinology, diabetes & metabolism specialist in Metairie, Louisiana, USA. He is current Chief, Endocrinology at the Tulane University School of Medicine.

Dr. Fonseca will start the webinar with his talk about the benefits HbA1c POC testing may provide.

Dr. Yasuhiro Iijima is diabetologist and director at the Fujiyasu Clinic and works also at the Department of Diabetes Metabolism and Endocrinology at Tokyo Medical University, Japan. Dr. Iijima will present his experience with POC lipid testing.

PD Dr. Andreas Kistler is Department Chief of Internal Medicine at the Kantonsspital Frauenfeld in Zurich, Switzerland. Dr. Kistler will share which impact the availability of ACR testing at the point-of-Care has on the identification and management of kidney disease.

Share
Like
Tweet

Präsentationen

  • Dr. Vivian Fonseca

    Dr. Vivian Fonseca
    (USA)
    Chair

    The Value of point-of-care testing in Diabetes

  • PD Dr. Andreas David Kistler

    PD Dr. Andreas David Kistler
    (SWITZERLAND)
    Speaker

    Relevance of determining albuminuria in the practice

  • Dr. Yasuhiro Iijima

    Dr. Yasuhiro Iijima
    (JAPAN)
    Speaker

    Immediate lipid testing with POC is effective and attractive for the treatment and education of outpatients

Live stream will be held in English, Japanese, Spanish, Brazilian-Portuguese, German and Italian. Available on demand in two additional languages: French and Korean.

Die dargestellten Ansichten und Meinungen stammen ausschließlich von den Autoren. Der in diesem Webcast enthaltene Inhalt ist nur für Informations-/Bildungszwecke bestimmt.

© 2023 Abt. Alle Rechte vorbehalten. Alle genannten Marken sind Marken der Abbott-Unternehmensgruppe oder ihrer jeweiligen Eigentümer. COL-00000

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"de","eventsSlug":"advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"de","eventsSlug":"advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"} 200 "https://campus.meplis.com/mypocacademy/ww/de/events/advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"de","eventsSlug":"advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"} 200 "https://campus.meplis.com/mypocacademy/ww/de/events/advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/de/events/advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"

"-- SEO4AJAX --" "Bugsnag Called"